1. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1036,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1136KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
2. |
Will sevoflurane oust propofol as the preferred induction anaesthetic? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1036,
1996,
Page 3-4
Gill Higgins,
Preview
|
PDF (2187KB)
|
|
摘要:
IV propofol is the standard agent used for induction of anaesthesia. It provides a rapid response and appears to be well accepted by patients. However, it also has certain disadvantages. These may be overcome by the new inhalational agent sevoflurane. Comparative studies have shown that sevoflurane is associated with less apnoea and cough, and a faster emergence from anaesthesia, compared with propofol. It also appears to be significantly cheaper. At the World Congress of Anaesthesiologists [Sydney, Australia; April 1996], experts in this field put forward the case for sevoflurane, and highlighted certain properties that render the agent particularly useful in elderly and paediatric patients.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
3. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1036,
1996,
Page 4-4
&NA;,
Preview
|
PDF (1071KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1036,
1996,
Page 5-5
&NA;,
Preview
|
PDF (989KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
5. |
Reviewing new antiparasitic treatments |
|
Inpharma Weekly,
Volume &NA;,
Issue 1036,
1996,
Page 6-6
&NA;,
Preview
|
PDF (1159KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
6. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1036,
1996,
Page 7-7
&NA;,
Preview
|
PDF (1014KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
7. |
Neutrons target arthritis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1036,
1996,
Page 8-8
&NA;,
Preview
|
PDF (1010KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
8. |
Progress report on the topoisomerase I inhibitors |
|
Inpharma Weekly,
Volume &NA;,
Issue 1036,
1996,
Page 9-10
Robert Short,
Preview
|
PDF (2172KB)
|
|
摘要:
In the 30 years since the discovery of camptothecin, several companies have pursued the development of camptothecin analogues as treatments for cancer. One of these analogues, irinotecan, has now been launched. Topotecan is not far behind, while the rest are in clinical or preclinical investigations. The current status of these drugs was discussed at the 9th National Cancer Institute/European Organisation for the Research and Treatment of Cancer (NCI-EORTC) symposium [Amsterdam, The Netherlands; March 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
9. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1036,
1996,
Page 10-10
&NA;,
Preview
|
PDF (1072KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
10. |
Three regimens compared in AIDS-associated PCP |
|
Inpharma Weekly,
Volume &NA;,
Issue 1036,
1996,
Page 11-11
&NA;,
Preview
|
PDF (1000KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|